470Authorisations under opioid dependency treatment

470 Authorisations under opioid dependency treatment (1) An opioid dependency treatment licence issued to a pharmacist authorises the licence-holder, and any other pharmacist at the community pharmacy (the licensed pharmacy) to which the licence relates, to do any of the following for the purpose of treating a person’s drug-dependency: (a) issue a purchase order for buprenorphine or methadone; (b) obtain buprenorphine or methadone on a purchase order for administration at the licensed pharmacy; (c) possess buprenorphine and methadone; (d) dispense buprenorphine and methadone in accordance with a

Opioid dependency treatment licence authorisations Division 9.5.4 (e) supply buprenorphine and methadone to a nurse at the licensed pharmacy for administration at the pharmacy under the supervision of a pharmacist; (f) administer buprenorphine and methadone at the licensed pharmacy in accordance with a prescription (including the prescription as changed by a pharmacist at the oral direction of the prescriber). (2) An opioid dependency treatment licence issued to a pharmacist authorises a nurse to administer buprenorphine and methadone at the licensed pharmacy under the supervision of a pharmacist and in accordance with a prescription (including the prescription as changed by a pharmacist at the oral direction of the prescriber). Note 1 Nurse does not include an enrolled nurse (see Legislation Act, dict, pt 1). (3) To remove any doubt, an authorisation under this section does not, by implication, limit a pharmacist’s or nurse’s authorisations under schedule 1 (Medicines—health-related occupations authorisations) in relation to other dealings with buprenorphine and methadone.